Cancer Prevention Group Blog

Cancer Prevention Group Blog

Research Today, Cancer Prevention Tomorrow

HPV Vaccination

Cervical Cancer Elimination in Africa: where are we now and where do we need to be?

February 10, 2023 Jane Rigney 0

Union for International Cancer Control (UICC), International Agency for Research on Cancer (IARC), and African Cancer Registry Network (AFCRN)   In April 2022, the UICC […]

The Pathway to Cervical Cancer Elimination in Australia: An Interview with Megan Smith

January 25, 2023 Jane Rigney 0

Associate Professor Megan Smith (PhD MPH BE) is a lead researcher in the Cervical Cancer and HPV Stream at the Daffodil Centre, a joint venue between […]

The Fight for Global Health Equity: Eliminating Cervical Cancer

January 23, 2023 Peter Sasieni 0

Cervical Cancer Prevention Week 2023 Today marks the start of  Cervical Cancer Prevention Week: 23rd–29th January 2023. To celebrate, we are sharing a speech made […]

From Unlikely Allies to Global Elimination Strategy: the history of HPV and cervical cancer

January 13, 2023 Jane Rigney 0

This post is based on a longer, extended article from Lilly Matson, Cancer Research UK: Into the Archives: the story of HPV and cervical cancer […]

Cancer Prevention Group’s 2022 Christmas Reading List

December 15, 2022 Jane Rigney 0

As another year draws to a close, what better way to recharge over the festive break than to dive into our 2022 paper round-up. Sticking […]

‘The tragedy of thousands who need not die’: A history of cervical screening in England Part II

June 10, 2022 Jane Rigney 0

This post follows ‘A history of cervical screening in England Part I’ written by guest author Scarlett Dargan. Scarlett read History at Churchill College, Cambridge. She […]

HPV Vaccination in Japan: The Journey to Resuming a National Immunisation Programme

May 27, 2022 Jane Rigney 0

This post was written by guest author Maddie Rose Baker. Maddie is an International Journalism Master’s student at City, University of London. She also is a […]

HPV Vaccination, past & future: An interview with Judith Breuer

November 19, 2021 Jane Rigney 0

Professor Judith Breuer FMedSci is Professor of Virology and Co-Director of the Division of Infection and Immunity at UCL, and Consultant Clinical Virologist at Great […]

From assessing attitudes to a hypothetical HPV vaccine to seeing the real impact on cancer rates: reflections on 15 years of HPV vaccine behavioural science

November 12, 2021 Jane Rigney 0

This post was written by Dr Jo Waller & Dr Laura Marlow. Jo is a reader in cancer behavioural science & has a particular interest […]

HPV Vaccination, from theory to practice: An interview with Margaret Stanley

November 4, 2021 Jamie Doorbar 1

Prof Margaret Stanley is the Emeritus Professor of Epithelial Biology in the Division of Cellular and Molecular Pathology at the University of Cambridge, Department of […]

Vaccine hesitancy and disease prevention – It’s not just coronavirus which stands to lose

August 11, 2020 Jane Rigney 3

In this post Rose Brade, International Policy Advisor at Cancer Research UK provides her personal experiences with vaccine hesitancy and the implications for cervical cancer […]

Posts navigation

1 2 »

Welcome to the King’s Cancer Prevention blog

This blog is supported by the Early Cancer Institute at the University of Cambridge.

Cancer Prevention: About us

We are a group of epidemiologists and population researchers studying the causes of or early events in the development of cancer. Our aim is to be able to interfere and prevent cancer or diagnose it whilst still easy to treat.

Contact us at cancerprev@kcl.ac.uk

Follow us on Social Media

TWITTER FEED

Tweets by CancerPrev_KCL

Latest Posts, Tags & Comments
  • Meet our team!
  • 5 minutes with: Professor Stephen Duffy
  • In Conversation with Professor Shaun Treweek
  • Achieving earlier diagnosis of cancer: How can the wider primary care team contribute?
  • Findings from the ProtecT trial: A prostate cancer ‘good news’ story
  • Neurodiversity Celebration Week 2023 – Dyspraxia in the Workplace
  • HPV Awareness Day Round-up
  • 5 minutes with: Professor Rebecca Fitzgerald
  • Cervical Cancer Elimination in Africa: where are we now and where do we need to be?
  • Cervical Screening and HPV Self-Sampling in Denmark
Barrett’s oesophagus Best 3 cancer prevention cancer screening cervical cancer cervical screening Clinical research network clinical trials COVID-19 Cytosponge™ five minutes with health inequalities HPV HPV primary screening HPV vaccination mammography medical research Oesophageal cancer public health public policy screening self-sampling sensitivity Upper GI Women in Science
  • PTS Terbaik Bandung: Very creative..I like the discussion and writing about this article. Hopefully this article can add insight for readers.
  • Eiram: It's important to work on preventing it. https://lfu.edu.krd/
  • What are women’s views of personalised breast cancer risk assessment and risk-stratified breast screening? – Cancer Prevention Group Blog: […] Autumn, we posted a blog that outlined why the introduction of risk-stratification to the NHS Breast Screening Programme is…
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2023 | WordPress Theme by MH Themes